Several top international experts in artificial intelligence met for a B·Debate session, an initiative of Biocat and the “la Caixa” Foundation, to discuss the benefits and risks of AI, specifically but not exclusively online and on social media.
More and more, medicine strives for a greater level of precision. And it has an increasingly important ally: imaging techniques. In order to discuss some of the most recent and important advances, several of the top experts in the world came together convened by B·Debate.
Rare diseases each, by definition, affect only a handful of people. However, there are more than 7,000 different types and they affect roughly 10% of the global population. Researchers from around the world gathered at B·Debate to discuss the new advances in drug repurposing for rare diseases.
We want to know what was the main lesson learned from 2016 in the field of healthcare and the life sciences in Catalonia. We asked some of the key stakeholders in the sector: entrepreneurs, institutions, executives at hospitals and research centers and investors. This is what they told us: